What has been reviewed, and by whom.
Micelle 60 is in development and this company is small. Some of the review a larger organization would have completed before publishing a website has not been completed here. Rather than leave that to inference, this page states it.
Approved by the company. The product information, its development status, the description of the CMS programme, the company and legal pages, and the way services are described are approved by Micelle's management. Where a fact is not yet settled, the page says so.
Clinical content. The pages in Understanding CBD describe what is and is not known about cannabinoids in general. They are currently reviewed and approved by executive management and have been submitted to our Chief Scientific Officer for scientific review. Each page will be updated to show her name and the date when she has signed it. Until then, the pages carry the note Scientific review pending.
Not yet reviewed externally. At the date below, the following have not been reviewed by an outside party: our website copy by external regulatory counsel; our privacy notice and terms by external privacy counsel; our quality statements by an appointed quality approver; our safety information by an appointed pharmacovigilance officer; our accessibility by a manual audit with assistive technology. Each of these is being arranged, and this page records when each is complete.
What that means for you. Nothing on this website is a medical claim, and no product is offered for sale here. If you are a care organization evaluating Micelle 60, your own counsel and quality functions should review anything you intend to rely on, and we will provide what they ask for. If you are a patient or caregiver, the decisions that matter are made with your own care team, not on this site.
Last updated. September 16, 2026.
| Item | Status shown | Updated when |
|---|---|---|
| Website copy, external regulatory counsel | Not yet reviewed | Counsel engaged and review complete |
| Privacy notice and terms, external privacy counsel | Not yet reviewed | As above |
| Quality statements, appointed quality approver | Not yet appointed | Appointment made and review complete |
| Safety information, appointed pharmacovigilance officer | Not yet appointed | As above |
| Accessibility, manual audit with assistive technology | Automated testing only | Manual audit complete |
| Clinical education pages | Reviewed by executive management; submitted for scientific review | Each page as the Chief Scientific Officer signs it |